BNC KOREA. Inc. 256840

KRX · South Korea · Retail Trade

KRW 3,275.00+15.00 (+0.46%)

Market closed· Oct 1, 2026, 6:30 AM UTC· KRW · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

BNC KOREA. Inc. 256840

KRX · South Korea · Retail Trade

KRW 3,275.00+15.00 (+0.46%)

Market closed· Oct 1, 2026, 6:30 AM UTC· KRW · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-16.13% · 6MFull-screen chart

Open KRW 3,265.00High KRW 3,395.00Low KRW 3,190.00Close KRW 3,275.00Volume 4.71M

Oct 1, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: KRW 3,260.00
Volume: 0
Market cap: KRW 222.97B
Dividend yield (annualized): 2.15%
Avg. volume (1Y): 1.67M

Performance

1 week

-4.38%

1 month

+17.59%

3 months

+25.24%

6 months

-11.37%

Year to date

-28.18%

1 year

-33.26%

Total return, dividends included.

Company profile

Sector: Retail Trade
Industry: Specialty Stores
Country: South Korea
Exchange: KRX
Shares outstanding: 68.39M
Employees: 295
ISIN: KR7256840000
Beta: 0.55

Technical view

Mixed

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceJan 26, 2026

Leios Therapeutics and BNC Korea Announce Strategic Collaboration to Accelerate Development of 10XB-101 in South Korea

10XB-101 Being Developed for Focal Fat Reduction and Body ContouringLA JOLLA, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Leios Therapeutics, a clinical-stage biotechnology company focused on innovative aesthetic therapies, today announced the execution of a licensing agreement for 10XB-101, its investigational product for focal fat reduction and body contouring, along with a strategic equity investment by BNC Korea (KOSDAQ:256840), a leading healthcare and aesthetics-focused company in South Kore

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.